Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
filingDate |
2009-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2011-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-WO2009113495-A1 |
titleOfInvention |
Method for testing liver cancer using liver cancer-specific expression gene and therapeutic and preventive agent for liver cancer |
abstract |
An object of the present invention is to provide a test method, a test drug, and a kit thereof that can identify liver cancer easily and with high probability without using a contrast medium. An object is to evaluate and select substances for treating and preventing liver cancer, and to provide a therapeutic and preventive agent for liver cancer containing the obtained substance as an active ingredient. The above object is directed to a method for examining liver cancer using as an index at least one expression level selected from the group consisting of AKR1B10 gene, HCAP-G gene, TPX2 gene and their expression products that are specifically expressed in liver cancer cells, liver cancer It is solved by providing a method for evaluating / selecting a substance that decreases the expression level and a composition for treating and preventing liver cancer containing the substance as an active ingredient. |
priorityDate |
2008-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |